期刊文献+

新型牙髓病治疗材料硅酸盐水泥的生物相容性评估 被引量:1

Assessment of the biocompatibility of Portland cement, a novel treatment material for endodontic disease
下载PDF
导出
摘要 目的评估硅酸盐水泥(PC)的生物相容性。方法参考GB/T16175标准,将PC、无机三氧化聚合物(MTA)、无菌硅胶管(阴性对照组)直接埋入SD大鼠背部皮下,分别在术后7、30、90 d观察材料与组织界面的局部炎症反应。按GB/T16886标准,通过急性溶血实验评估材料的血液相容性。采用单因素方差分析比较组间炎症细胞数,LSD-t检验进行组间两两比较。结果植入实验术后7 d,PC组、MTA组、阴性对照组炎症反应程度均表现为Ⅱ级炎症反应,PC组、MTA组炎症细胞数差异无统计学意义,但阴性对照组炎细胞数明显少于两实验组。30 d时,两实验组和阴性对照组炎症反应程度均较7 d时低,炎症反应表现为Ⅰ级炎症反应,3组间炎症细胞数差异无统计学意义。90 d时,各组炎症细胞数极少,各组间差异无统计学意义。溶血实验表明PC、MTA溶血率分别为1.02%、1.09%,符合小于5%的标准。结论初步认为PC是一种生物相容性较好的生物材料。 Objective To assess the biocompatibility of Portland cement (PC). Methods According to GB/ T16175 standard, we embedded the PC, mineral trioxide aggregate (MTA), and sterile silicone tube (negative control group) in the back of SD rats subcutaneously. Local inflammation at the interface between materials and tissue was observed 7, 30, and 90 d after embedment. The acute hemolytic experiment was conducted to assess the blood compatibility of materials according to GB/T16886 standard. One-way ANOVA was used to analyze the difference of inflammatory cell numbers among groups and LSD-t was used as multiple comparison methods. Results The PC group, MTA group and negative control group all showed a class 1/ inflammation reaction 7 d after embedment. There was no significant difference in inflammatory cell number between the PC group and the MTA group, however, the inflammatory cell number in the negative control group was significantly less than those in two experiment groups. All three groups showed a class I inflammation reaction at 30 d, which was alleviated as compared with that seen at 7 d, meanwhile the inflammatory cell numbers in three groups had no significant difference. The inflammatory cells in all groups were very few with no difference between groups at 90 d. The hemolytic experiment showed that hemolysis rates in the PC group and the MTA group were 1.02% and 1.09%, which conformed to the standard of less than 5%. Conclusion It can be preliminarily concluded that PC is an biological material with favorable biocompatibility.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2016年第4期496-500,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 重庆市基础科学与前沿技术研究专项(cstc2014jcyj A10010)~~
关键词 硅酸盐水泥 无机三氧化聚合物 生物相容性 牙髓病 治疗材料 Pordand cement mineral trioxide aggregate biocompatible endodontic disease treatment material
  • 相关文献

参考文献19

  • 1Prati C, Gandolfi MG. Calcium silicate bioactive cements: biological perspectives and clinical applications[J]. Dent Mater, 2015, 31 (4) : 351 -370.
  • 2Parirokh M, Torabinejad M. Mineral trioxide aggregate: a compre- hensive literature review : Part Ⅱ. clinical applications, drawbacks, and mechanism of action[J]. J Endod, 2010, 36(3): 400-413.
  • 3Asgary S, Parirokh M, Eghbal MJ, et al. A comparative study of white mineral trioxide aggregate and white Portland cements using X-ray microanalysis [ J ]. Aust Endod J, 2004, 30 (3) : 89 - 92.
  • 4Marciano MA, Duarte MA, Camilleri J. Dental discoloration caused by bismuth oxide in MTA in the presence of sodium hypochlorite [J]. Clin Oral Investig, 2015, 19(9): 2201 -2209.
  • 5穆云静.可固化氢氧化钙根管封闭剂生物相容性及根尖封闭性研究[D].西安:第四军医大学,2013.
  • 6国家质量监督检验检疫总局.GB/T16175-2008医用有机硅材料生物学评价实验方法[S].北京:中国标准出版社,2008.
  • 7国家质量监督检验检疫总局.GB/T16886-2003医疗器械生物学评价[S].北京:中国标准出版社,2003.
  • 8Torabinejad M, Parirokh M. Mineral trioxide aggregate: a compre- hensive literature review: Part Ⅱ. leakage and biocompatibility investigations[J]. J Endod, 2010, 36(2) : 190 -202.
  • 9Durate MA, Demarchi AC, Yamashita JC, et al. Arsenic release provided by MTA and Portland cement [ J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2005, 99 (5) : 648 -650.
  • 10Hernandez EP, Botero TM, Mantellini MG. Effeet of ProRoot MTA mixed with chlorhexidine on apoptosis and cell cycle of fibroblasts and macrophagesin vitro[J]. Int Endod J, 2005, 38(4): 137- 143.

二级参考文献38

共引文献18

同被引文献4

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部